Table 3.
The Genotypes Distributions of the MMPs Polymorphisms Among Controls and Patients
| Patient group n (%) | Control group n (%) | P‐value | ||
|---|---|---|---|---|
| MMP‐9 | TT | 77 (52.93) | 62 (40.56) | <0.05 |
| TC | 57 (39.65) | 76 (46.25) | ||
| CC | 11 (7.42) | 19 (13.19) | ||
| TC+TT | 134 (92.41) | 138 (87.89) | ||
| T | 211 (72.76) | 200 (63.70) | ||
| C | 79 (27.24) | 114 (36.30) | ||
| PON1 | 42 (28.56) | 73 (45.58) | <0.01 | |
| QR | 71 (49.77) | 66 (43.87) | ||
| RR | 32 (21.67) | 18 (10.55) | <0.05 | |
| QR+RR | 103 (71.03) | 84 (53.50) | ||
| Q | 155 (53.45) | 212 (67.51) | ||
| R | 135 (46.55) | 102 (32.49) |
MMP, matrix metalloproteinase; PON1, paraoxonase1.